High prevalence of penicillin-nonsusceptible streptococcus pneumoniae at a community hospital in oklahoma

Emerging Infectious Diseases

Volumn 6, Issue 3, 2000, Pages 283-289

  Moolenaar, Ronald L ^a,b   Pasley Shaw, Ronda ^c   Harkess, John R ^c   Lee, Anthony ^b   Crutcher, James M ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b OKLAHOMA STATE DEPARTMENT OF HEALTH   (United States)

^c Mercy Health Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; COTRIMOXAZOLE; OXACILLIN; PENICILLIN G;

ANTIBIOTIC SENSITIVITY; ARTICLE; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; LABORATORY DIAGNOSIS; NONHUMAN; PENICILLIN RESISTANCE; PREVALENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0034124996     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0603.000308     Document Type: Article

References (27)

1. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994;271:1831-5.
2. Butler JC, Hoffman J, Cetron MS, Elliott JA, Facklam RR, Breiman RF, et al. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's pneumococcal sentinel surveillance system. J Infect Dis 1996;174:986-93.
3. Centers for Disease Control and Prevention. Defining the public health impact of drug-resistant Streptococcus pneumoniae: report of a working group. MMWR Morb Mortal Wkly Rep 1996;45(RR-1):1-20.
4. Pastor P, Medley F, Murphy TV. Invasive pneumococcal disease in Dallas County, Texas: results from population-based surveillance in 1995. Clin Infect Dis 1998;26:590-5.
5. Hoffman J, Cetron MS, Farley MM, Baughman WS, Facklam RR, Elliott JA, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995;333:481-6.
6. Heffernan R, Henning K, Labowitz A, Hjelte A, Layton M. Laboratory survey of drug-resistant Streptococcus pneumoniae in New York City, 1993-1995. Emerg Infect Dis 1998;4:113-6.
7. Butler JC, Cetron MS. Pneumococcal drug resistance: the new "special enemy of old age." Clin Infect Dis 1999;28:730-5.
8. Centers for Disease Control and Prevention. Geographic variation in penicillin resistance in Streptococcus pneumoniae - selected sites, United States, 1997 MMWR Morb Mortal Wkly Rep 1999:48;656-61.
9. Istre GR, Tarpay M, Anderson M, Pryor A, Welch D, the Pneumococcus Study Group. Invasive disease due to Streptococcus pneumoniae in an area with a high rate of relative penicillin resistance. J Infect Dis 1987;156:732-5
10. Haglund LA, Istre GR, Pickett DA, Welch DF, Fine DP, and the Pneumococcus Study Group. Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. J Infect Dis 1993;168:1532-6.
11. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing (5th informational supplement). NCCLS document no. M100-S5. Villanova, PA: The Committee, 1994.
12. Nuorti JP, Butler JC, Crutcher JM, Guevara R, Welch D, Holder I, et al. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med 1998;338:1861-8.
13. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997:46(RR-8):1-24.
14. Macias EA, Mason EO Jr, Ocera HY, La Rocco MT. Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae. J Clin Microbiol 1994;32:430-2.
15. Tenover FC, Baker CN, Swenson JM. Evaluation of commercial methods for determining antimicrobial susceptibility of Streptococcus pneumoniae. J Clin Microbiol 1996;34:10-4.
16. Jernigan DB, Cetron MS, Breiman RF. Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP): a strategy from the DRSP Working Group. JAMA 1996;275:206-9.
17. Chin AE, Hedberg K, Cieslak PR, Cassidy M, Stefonek KR, Fleming DB. Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method. Emerg Infect Dis 1999;5:688-93.
18. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination levels among adults aged greater than or equal to 65 years - United States. MMWR Morb Mortal Wkly Rep 1998:47;797-802.
19. Klein RS, Adachi N. An effective hospital-based pneumococcal immunization program. Arch Intern Med 1986;146:327-9.
20. Vondracek TG, Pham TP, Huycke MM. A hospital-based pharmacy intervention program for pneumococcal vaccination. Arch Intern Med 1998;158:1543-7.
21. Gyorkos TW, Tannenbaum TN, Abrahamowicz M. Evaluation of the effectiveness of immunization delivery methods. Can J Public Health 1994;85(Suppl):S14-30.
22. Centers for Disease Control and Prevention. Vaccine-preventable diseases: improving vaccination coverage in children, adolescents and adults. A report on recommendations of the Task Force on Community Preventive Services. MMWR Morb Mortal Wkly Rep 1999;48(RR-8):1-15.
23. Centers for Disease Control and Prevention. Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation - a report of the National Vaccine Advisory Committee and use of standing orders programs to increase adult vaccination rates: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2000;49(RR-1):1-13.
24. Bedos JP, Chevret S, Chastang C, Geslin P, Regnier B, and the French Cooperative Pneumococcus Study Group. Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French survey. Clin Infect Dis 1996;22:63-72.
25. Nava JM, Bella F, Garau J, Lite J, Morera MA, Marti C, et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population based study. Clin Infect Dis 1994;19:884-90.
26. Frick PA, Black DJ, Duchin JS, Delaganis S, Mckee WM, Fritsche TR. Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington state. West J Med 1998;169:364-9.
27. Gonzales R, Steiner JF, Lum A, Barret PH. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999;281:1512-9.